Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
06/2010
06/29/2010CA2336967C A3 adenosine receptor antagonists
06/24/2010WO2010071223A1 Novel organic compound
06/24/2010WO2010070615A1 Cysteine protease inhibitors
06/24/2010WO2010070076A1 Alkanoic acid derivatives and their therapeutic use as hdac inhibitors
06/24/2010WO2010069834A1 Novel herbicides
06/24/2010WO2010069802A1 Heterocyclic diketone derivatives with herbicidal action
06/24/2010WO2010069495A1 Atpenins
06/24/2010WO2010069494A1 Use of 5-pyridin-4yl(1,3)thiazole for treating phytopathogenic fungi
06/24/2010WO2010069069A1 Cathepsin b inhibitors
06/24/2010US20100160641 Process for producing dihalopyridines
06/24/2010US20100160632 Bisamid-zinkbasen
06/24/2010US20100160391 Substituted Aminopyridines as Fluorescent Reporters for Amide Hydrolases
06/24/2010US20100160390 Compounds capable of activating cholinergic receptors
06/24/2010US20100160389 Dihydropyridone amidesas p2x7 modulators
06/24/2010US20100160388 Dihydropyridone ureas as p2x7 modulators
06/24/2010US20100160387 Dihydropyridone amides as p2x7 modulators
06/24/2010US20100160386 4-phenoxy-nicotine acid derivatives and use thereof as ppar-modulators
06/24/2010US20100160385 Fungicidal triphenyl-substituted pyridones
06/24/2010US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160328 New compounds useful for dpp-iv enzyme inhibition
06/24/2010US20100160327 Modified Malonate Derivatives
06/24/2010US20100160326 Pest control agent containing novel pyridyl-methanamine derivative or salt thereof
06/24/2010US20100160307 Method for controlling particular insect pests by applying anthranilamide compounds
06/24/2010US20100160292 Kinase Inhibitors, and Methods of Using and Identifying Kinase Inhibitors
06/24/2010US20100160280 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
06/24/2010US20100160263 7,9-substituted tetracycline compounds
06/24/2010US20100159593 Transfection reagents
06/24/2010US20100158996 Ester compound and medical use thereof
06/24/2010US20100155714 Organic electroluminescent device
06/24/2010CA2747303A1 Use of 5-pyridin-4yl(1,3)thiazole for treating phytopathogenic fungi
06/24/2010CA2746961A1 Novel herbicides
06/24/2010CA2744888A1 Cysteine protease inhibitors
06/23/2010EP2199282A1 Amide compound
06/23/2010EP2198710A1 Use of 5-pyridin-4yl-(1,3) thiazoles for combating phytopathogenic fungi
06/23/2010EP2197846A1 Substituted 6-pheylnicotinic acids and the use thereof
06/23/2010EP2197845A1 Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof
06/23/2010EP2197841A2 Guanidine-containing compounds useful as muscarinic receptor antagonists
06/23/2010EP2197835A1 Bicyclic aryl and heteroaryl receptor modulators
06/23/2010EP2197832A1 Novel aryl potassium channel blockers and uses thereof
06/23/2010EP2197829A2 Arylamine synthesis method
06/23/2010EP2197271A2 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
06/23/2010CN1910176B Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
06/23/2010CN1906155B Novel hydroxamic acid ester derivant and pharmaceutical use thereof
06/23/2010CN1835751B Therapeutic agents useful for treating pain
06/23/2010CN101747320A Dialdehyde-built disinsection activity-having nitrogen or oxygen-containing heterocyclic compound and preparation method
06/23/2010CN101747263A Pyridyloxy phenoxyalkanoic acids compound and application
06/23/2010CN101747262A Electron transporting-injection material and organic electroluminescent device using the same
06/23/2010CN101747261A Method for preparing 4-[4-(1-piperidinyl) pyridine-2-O]-cis-2-butene-1-ol
06/23/2010CN101747260A Preparation method of ionic liquid
06/23/2010CN101747171A Method for fast synthesizing 3-substituted aromatic acid
06/23/2010CN101747170A Conjugated type coenzyme Q analogue, preparation method and application thereof
06/23/2010CN101745385A Preparation method of load type palladium/shell powder catalyst
06/23/2010CN101302193B Entironment-friendly preparation of sorafenib intermediate
06/23/2010CN101177410B Method for synthesizing 2-substituted enamine or enamides
06/22/2010US7741519 Bis-aryl sulfonamides
06/22/2010US7741486 represented by the chemical formula (OC6H6N)2Ti(OC6H2(CH2N(CH3)2)3-2,4,6)2 ; hexavalent titanium atom bonded to two OC6H6N groups and two OC6H2(CH2N(CH3)2)3-2,4,6 groups with a theoretical molecular weight of 792.8; water stability
06/22/2010US7741352 for the treatment or alleviation of pain, headaches, nervous system disorders or trauma, stroke, neurodegenerative diseases, cardiovascular disorders, inflammatory diseases, vision defects, hearing disorders, respiratory system disordres and urinary incontinence
06/22/2010US7741346 Vision defects; anticancer agents; antitumor agents
06/22/2010US7741339 Fab I inhibitors
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010US7741323 6-methoxy-1-(trans-methylimino-N-oxy)-3-phenyl-1H-indene-2-carboxylate ethyl ester, used for selectively modulating the activities of peroxisome proliferator activated receptors; excellent effect in lowering both blood glucose and insulin levels; side effect reduction
06/22/2010US7741102 Surface enhanced (resonance) Raman scattering with 2,4,6-trinitrostyryl-1H-benzotriazole; for detection of explosives and drugs; drug screening
06/22/2010US7740954 Reacting an unsaturated group in a chemoselective manner to form a less unsaturated group to modify a dendron intended to form a dendrimer; organic light emitters (OLED); using dendrons that contain acetylene and vinylene links between branching points and further reacting them
06/22/2010CA2552158C Catalyst for synthesis of 2- and 4-picolines, process for preparing 2- and 4-picoline and process for preparing the catalyst
06/22/2010CA2420996C Substituted heterocyclic compounds for treating multidrug resistance
06/22/2010CA2401655C Cardioprotective phosphonates and malonates
06/22/2010CA2315715C Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
06/22/2010CA2233550C Symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
06/17/2010WO2010068262A1 Processes and intermediates for carbamoylpyridone hiv integrase inhibitors
06/17/2010WO2010067990A2 Novel 6-indazolylamino-3-nitro pyridine derivative compound, method for preparing same, and pharmaceutical composition including same
06/17/2010WO2010067989A2 Novel 2,6-substituted-3-nitropyridine derivative, method for preparing same, and pharmaceutical preparation including same
06/17/2010WO2010067988A2 Novel 3-nitropyridine derivative substituted at 2,6-loci, method for preparing the same, and pharmaceutical preparation including the same
06/17/2010WO2010067987A2 Novel 2,6-substituted-3-nitropyridine derivative, method for preparing same, and pharmaceutical composition including same
06/17/2010WO2010067442A1 Method for producing alcohol compound
06/17/2010WO2010067085A2 Synthesis of 9-(arylalkyl)-1,2,3,4-tetrahydro-υ-carboline and analogues and intermediates
06/17/2010WO2010066847A1 Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-hiv agents
06/17/2010WO2010066709A1 Novel pyridinyl acrylamide derivatives
06/17/2010WO2010066682A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
06/17/2010WO2010066669A1 Process for manufacturing substituted 5-methoxymethylpyridine-2,3-dicarboxylic acid derivatives
06/17/2010WO2010066668A1 Process for manufacturing 5-formyl-pyridine-2,3-dicarboxylic acid esters
06/17/2010WO2010066658A1 Compounds which potentiate the ampa receptor and uses thereof in medicine
06/17/2010WO2010066380A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
06/17/2010WO2010013141A3 Substantially pure rosiglitazone hydrogen sulfate
06/17/2010US20100152252 Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments
06/17/2010US20100152251 Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
06/17/2010US20100152245 Insecticidal n-substituted (6-halooalkylpyridin-3-yl)-alkyl sulfoximines
06/17/2010US20100152237 Bis-pyrindino containing compounds for the use in the treatment of cns pathologies
06/17/2010US20100152220 Indene derivatives as pharmaceutical agents
06/17/2010US20100152207 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
06/17/2010US20100152098 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
06/17/2010CA2748691A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
06/17/2010CA2745843A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
06/17/2010CA2744368A1 Process for manufacturing substituted 5-methoxymethylpyridine-2,3-dicarboxylic acid derivatives
06/16/2010EP2196453A1 Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-HIV agents
06/16/2010EP2195330A1 Method and agent for refolding proteins
06/16/2010EP2195328A1 Certain chemical entities, compositions, and methods
06/16/2010EP2195312A1 Pyridine derivatives useful as glucokinase activators
06/16/2010EP2195302A2 Insecticidal substituted azinyl derivatives
06/16/2010EP2195288A2 Small molecule bradykinin b1 receptor antagonists